review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Penny A Dacks | Q58826145 |
Annapurna Poduri | Q88604309 | ||
Elizabeth A Felton | Q89772272 | ||
Vicky Holets Whittemore | Q92197201 | ||
P2093 | author name string | Jana E Jones | |
Miya R Asato | |||
Jennifer A Kearney | |||
Mesha-Gay Brown | |||
Julia L Doss | |||
Delia Talos | |||
NINDS/AES Benchmarks Stewards Committee | |||
P2860 | cites work | Recognizing and preventing epilepsy-related mortality: A call for action | Q26775482 |
Scoping review of patient- and family-oriented outcomes and measures for chronic pediatric disease | Q27026807 | ||
Spreading depolarization in the brainstem mediates sudden cardiorespiratory arrest in mouse SUDEP models | Q27325761 | ||
Management of psychogenic nonepileptic seizures | Q28286571 | ||
The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy. | Q30240627 | ||
Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy | Q30252671 | ||
Mapping genetic modifiers of survival in a mouse model of Dravet syndrome | Q30572370 | ||
Laser thermal ablation for mesiotemporal epilepsy: Analysis of ablation volumes and trajectories. | Q30850323 | ||
Suicide among people with epilepsy: A population-based analysis of data from the U.S. National Violent Death Reporting System, 17 states, 2003-2011. | Q31112002 | ||
Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Soci | Q33840272 | ||
Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures | Q34992471 | ||
Breathing Inhibited When Seizures Spread to the Amygdala and upon Amygdala Stimulation. | Q35851523 | ||
Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy | Q35876471 | ||
NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy | Q36520757 | ||
2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan | Q37021068 | ||
Priorities in pediatric epilepsy research: improving children's futures today | Q37227062 | ||
Cardiac arrhythmia in a mouse model of sodium channel SCN8A epileptic encephalopathy | Q37417878 | ||
The new approach to classification: rethinking cognition and behavior in epilepsy. | Q38273908 | ||
Fetal Growth and Premature Delivery in Pregnant Women on Anti-epileptic Drugs | Q38600924 | ||
Folic acid use by women with epilepsy: Findings of the Epilepsy Birth Control Registry | Q38729719 | ||
Epilepsy as a systemic condition: Link with somatic comorbidities. | Q38749358 | ||
Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey | Q38863377 | ||
Gene expression variance in hippocampal tissue of temporal lobe epilepsy patients corresponds to differential memory performance. | Q38936018 | ||
Counseling by epileptologists affects contraceptive choices of women with epilepsy | Q39003863 | ||
Psychological interventions for psychogenic non-epileptic seizures: A meta-analysis. | Q39034461 | ||
Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy | Q39035600 | ||
Serotonergic agents act on 5-HT3 receptors in the brain to block seizure-induced respiratory arrest in the DBA/1 mouse model of SUDEP. | Q39288824 | ||
Treating functional non-epileptic attacks - Should we consider acceptance and commitment therapy? | Q39397573 | ||
Contraceptive practices of women with epilepsy: Findings of the epilepsy birth control registry. | Q39994611 | ||
Occurrence and Recurrence of Attempted Suicide Among People With Epilepsy | Q40228788 | ||
Predictors of unintended pregnancy in women with epilepsy | Q40364434 | ||
Physical and mental health comorbidities of epilepsy: Population-based cross-sectional analysis of 1.5 million people in Scotland | Q40407250 | ||
Risk factors for comorbid psychopathology in youth with psychogenic nonepileptic seizures | Q40796841 | ||
Prolongation of action potential duration and QT interval during epilepsy linked to increased contribution of neuronal sodium channels to cardiac late Na+ current: potential mechanism for sudden death in epilepsy | Q41676546 | ||
MRI-Guided stereotactic laser ablation for epilepsy surgery: Promising preliminary results for cognitive outcome | Q42694221 | ||
Antiepileptic drug use among women from the Taiwanese Registry of Epilepsy and Pregnancy: Obstetric complications and fetal malformation outcomes | Q47106987 | ||
Dysfunctional Brain Networking among Autonomic Regulatory Structures in Temporal Lobe Epilepsy Patients at High Risk of Sudden Unexpected Death in Epilepsy. | Q47120866 | ||
Optogenetic activation of 5-HT neurons in the dorsal raphe suppresses seizure-induced respiratory arrest and produces anticonvulsant effect in the DBA/1 mouse SUDEP model | Q47230471 | ||
Risk factors for learning problems in youth with psychogenic non-epileptic seizures | Q47326142 | ||
Prolonged exposure therapy for the treatment of patients diagnosed with psychogenic non-epileptic seizures (PNES) and post-traumatic stress disorder (PTSD). | Q47358287 | ||
Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial | Q47428484 | ||
Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero | Q47569415 | ||
Access to diagnostic and therapeutic facilities for psychogenic nonepileptic seizures: An international survey by the ILAE PNES Task Force-2nd Revision | Q47573106 | ||
A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures | Q47612224 | ||
Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate | Q47645532 | ||
Severe peri-ictal respiratory dysfunction is common in Dravet syndrome. | Q47658294 | ||
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany. | Q47733662 | ||
Mortality in Dravet syndrome | Q47888090 | ||
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience | Q47896081 | ||
Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP). | Q47917754 | ||
Short- and long-term complications of in utero exposure to lamotrigine | Q48169557 | ||
Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study | Q49547050 | ||
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. | Q49986031 | ||
Teratogenicity of antiepileptic dual therapy: Dose dependent, drug specific, or both? | Q50074566 | ||
Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study | Q50240434 | ||
Evaluation of cognitive functions of juvenile myoclonic epileptic patients by magnetic resonance spectroscopy and neuropsychiatric cognitive tests concurrently. | Q50692743 | ||
Risk Factors for Diagnostic Delay in Psychogenic Nonepileptic Seizures Among Children and Adolescents. | Q51016013 | ||
Sudden unexpected death in epilepsy: assessing the public health burden. | Q51248582 | ||
Serotonin neurones have anti-convulsant effects and reduce seizure-induced mortality. | Q51705118 | ||
PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task Force report. | Q52626479 | ||
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Soci | Q53336078 | ||
Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy | Q57543941 | ||
Risk of Unnatural Mortality in People With Epilepsy | Q57719626 | ||
Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents | Q58583545 | ||
Verbal abilities in children of mothers with epilepsy: Association to maternal folate status | Q58697668 | ||
Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes | Q58711098 | ||
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry | Q61849442 | ||
Postconvulsive central apnea as a biomarker for sudden unexpected death in epilepsy (SUDEP) | Q62868002 | ||
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome | Q62868237 | ||
Disordered breathing in a mouse model of Dravet syndrome | Q64084492 | ||
Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database | Q87239343 | ||
Cerebellar volume as an imaging marker of development in infants with tuberous sclerosis complex | Q88152352 | ||
Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations | Q88376689 | ||
Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy | Q88580032 | ||
Relating structural and functional brainstem connectivity to disease measures in epilepsy | Q88923928 | ||
Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex | Q89231705 | ||
Postconvulsive central apnea and asystole: A risk marker for sudden unexpected death in epilepsy (SUDEP)? | Q90646446 | ||
Regional cortical thickness changes accompanying generalized tonic-clonic seizures | Q90861802 | ||
Adherence with psychotherapy and treatment outcomes for psychogenic nonepileptic seizures | Q90891922 | ||
Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overview | Q91260473 | ||
Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum | Q91449935 | ||
Ventilatory response to CO2 in patients with epilepsy | Q91525686 | ||
Neural activity in the periaqueductal gray and other specific subcortical structures is enhanced when a selective serotonin reuptake inhibitor selectively prevents seizure-induced sudden death in the DBA/1 mouse model of sudden unexpected death in e | Q91772415 | ||
Impaired CO2-Induced Arousal in SIDS and SUDEP | Q92578438 | ||
The effect of seizure spread to the amygdala on respiration and onset of ictal central apnea | Q92880961 | ||
Cardiorespiratory profiling reveals primary breathing dysfunction in Kcna1-null mice: Implications for sudden unexpected death in epilepsy | Q93028319 | ||
P433 | issue | 1_suppl | |
P921 | main subject | lifetime | Q22675021 |
P304 | page(s) | 31S-39S | |
P577 | publication date | 2020-01-23 | |
P1433 | published in | Epilepsy Currents | Q5382972 |
P1476 | title | Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span | |
P478 | volume | 20 |
Search more.